FDA Orange Book · active-ingredient family
Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous is approved as 2 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:GOLYTELY · NDA 019011
2
Brand (NDA)
11
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · for solution, for suspension
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GOLYTELYRLD×2 | AZURITY | NDA 019011 | — | Jun 02, 1992 | |
| COLYTERLD×8 | STRIDES PHARMA INTL | NDA 018983 | — | Oct 26, 1984 |
Generic (ANDA) products (11)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | STRIDES PHARMA | ANDA 204558 | AA | Dec 21, 2018 | |
| POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | PADDOCK LLC | ANDA 090712 | — | Feb 25, 2010 | |
| PEG 3350 AND ELECTROLYTES | EXTROVIS | ANDA 090928 | — | Jan 28, 2010 | |
| PEG 3350 AND ELECTROLYTES | NOVEL LABS INC | ANDA 090231 | AA | Jun 01, 2009 | |
| PEG 3350 AND ELECTROLYTES | NOVEL LABS INC | ANDA 090186 | — | Jun 01, 2009 | |
| PEG-LYTE | SANDOZ | ANDA 073098 | — | Aug 31, 1993 | |
| GO-EVAC | VINTAGE PHARMS | ANDA 073433 | — | Apr 28, 1992 | |
| CO-LAV | VINTAGE PHARMS | ANDA 073428 | — | Jan 28, 1992 | |
| GLYCOPREP | GOLDLINE | ANDA 072319 | — | Dec 23, 1988 | |
| E-Z-EM PREP LYTE | E Z EM | ANDA 071278 | — | Nov 21, 1988 | |
| COLOVAGE | DYNAPHARM | ANDA 071320 | — | Apr 20, 1988 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

